🇧🇪 Belgium Country × Condition
transgenderism Clinical Trials in Belgium
Active clinical trials for transgenderism with research sites in Belgium. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇧🇪 Belgium
Active Trials in Belgium (4)
NCT06439290
Recruiting
Voice Outcome of Glottoplasty, Cricothyroid Approximation, Thyroplasty, and Chondrolaryngoplasty
Enrollment
290 pts
Country
🇧🇪 Belgium
University Ghent
View Trial → NCT05883553
Recruiting
Epithesis Versus Prosthesis in Post-phalloplasty Transgender Patients.
Enrollment
40 pts
Country
🇧🇪 Belgium
University Hospital, Ghent
View Trial → NCT06639776
Recruiting
Sexual Functioning After Erection Prosthesis Placement in Post Phalloplasty Transgender Persons
Enrollment
150 pts
Country
🇧🇪 Belgium
University Hospital, Ghent
View Trial → NCT06639763
Recruiting
Erectile Aid Use in Post-phalloplasty and Post-metoidioplasty Transgender Patients
Enrollment
1,000 pts
Country
🇧🇪 Belgium
University Hospital, Ghent
View Trial → Frequently Asked Questions
How many transgenderism clinical trials are active in Belgium?
There are currently 4 active clinical trials for transgenderism with sites in Belgium, of which 4 are actively recruiting patients.
How can I join a transgenderism clinical trial in Belgium?
To join a transgenderism clinical trial in Belgium, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Belgium directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are transgenderism trials in Belgium?
Active transgenderism trials in Belgium span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology